# MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia

> **NCT00545571** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 120 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Methoxy polyethylene glycol-epoetin beta

## Key facts

- **NCT ID:** NCT00545571
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545571, "MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00545571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*